← Back to Search

Dietary Supplement

Strawberry Powder for Obesity

N/A
Waitlist Available
Led By Sara Rosenkranz, PhD
Research Sponsored by Carl Ade, M.S., Ph.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, 4, 5, 9, 10, and 14
Awards & highlights

Study Summary

This trial will study the effects of strawberry consumption on adults at high risk for cardiovascular disease and diabetes.

Who is the study for?
This trial is for adults who are overweight or obese with a BMI of 25.0-34.9, have borderline-high LDL cholesterol (130-159mg/dL), and normal to slightly high blood pressure (up to 129mmHg/80mmHg). It's not for those taking certain supplements, pregnant or breastfeeding women, people with allergies to strawberries, diagnosed chronic diseases like diabetes, anemia or liver/thyroid/kidney conditions, smokers/tobacco users within the last three months, regular alcohol consumers (>1-2 drinks/day), or on chronic disease medications.Check my eligibility
What is being tested?
The study tests the effects of strawberry consumption on heart and metabolic health in at-risk adults. Participants will receive either mixed strawberry powder, active strawberry powder specifically designed for this study's purposes, or a placebo powder without active ingredients. The goal is to see if these powders can improve cardiovascular markers.See study design
What are the potential side effects?
Since the intervention involves consuming strawberry powders which are food-based products; side effects might be minimal but could include potential allergic reactions in sensitive individuals despite allergy being an exclusion criterion.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, 4, 5, 9, 10, and 14
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0, 4, 5, 9, 10, and 14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in plasma lipids
Secondary outcome measures
Change in arterial stiffness
Change in blood pressure (resting and 24-hr)
Change in endothelial function
+4 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Active strawberry powderExperimental Treatment1 Intervention
Participants will consume a 39g freeze-dried active strawberry powder beverage once per day for 4-weeks.
Group II: Mixed active/placebo strawberry powderActive Control1 Intervention
Participants will consume a 39g mixed active/placebo strawberry powder beverage once per day for 4-weeks.
Group III: Placebo strawberry powderPlacebo Group1 Intervention
Participants will consume a 39g freeze-dried strawberry powder placebo beverage once per day for 4-weeks.

Find a Location

Who is running the clinical trial?

California Strawberry CommissionOTHER
11 Previous Clinical Trials
493 Total Patients Enrolled
2 Trials studying Obesity
107 Patients Enrolled for Obesity
Carl Ade, M.S., Ph.D.Lead Sponsor
1 Previous Clinical Trials
60 Total Patients Enrolled
Sara Rosenkranz, PhDPrincipal InvestigatorKansas State University
2 Previous Clinical Trials
37 Total Patients Enrolled
1 Trials studying Obesity

Media Library

Active strawberry powder (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04094103 — N/A
Obesity Research Study Groups: Placebo strawberry powder, Active strawberry powder, Mixed active/placebo strawberry powder
Obesity Clinical Trial 2023: Active strawberry powder Highlights & Side Effects. Trial Name: NCT04094103 — N/A
Active strawberry powder (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04094103 — N/A
~8 spots leftby Jun 2025